Insulin replaces or adds to the body’s own insulin to control blood sugar in type 1 and type 2 diabetes. Types differ in how fast and how long they work.
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
5 recalls since 2020
Mar 2024 · Eli Lilly & Company · Class II CGMP Deviations
Apr 2023 · Sanofi-Aventis U.S. LLC · Class II Lack of Assurance of Sterility: Malformed crimped collar seal
Apr 2022 · Cardinal Health Inc. · Class I TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Mar 2021 · Novo Nordisk Inc · Class I Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Mar 2021 · Novo Nordisk Inc · Class I Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.